Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev LtdfiledCriticalGlaxosmithkline Ip Dev Ltd
Priority claimed from PCT/US2013/059600external-prioritypatent/WO2014043437A1/en
Publication of MA37920A1publicationCriticalpatent/MA37920A1/en
L'invention concerne des composés ayant la formule suivante : (la formule chimique doit être insérée ici), dans cette formule, r1, r2, r3, r4 et r5 sont tels que définis dans la description; et des procédés de fabrication et d'utilisation de ceux-ci.The invention relates to compounds having the following formula: (the chemical formula must be inserted here), in this formula, r1, r2, r3, r4 and r5 are as defined in the description; and methods of making and using them.
MA37920A2012-09-132013-09-13
Amino-quinolines as kinase inhibitors
MA37920A1
(en)